Schroeder Mark S 4

4 · LABCORP HOLDINGS INC. · Filed Feb 13, 2025

Form 4

Period: 2025-02-11

EVP, Pres Diagnostics & COO

Transactions

Award
Non-qualified Stock Options
2025-02-11+7,300→ 7,300 total
Exercise: $245.14From: 2026-02-11Exp: 2035-02-10→ Common Stock (7,300 underlying)
Exercise/Conversion
Restricted Stock Unit
2025-02-11−473→ 4,588 total
→ Common Stock (473 underlying)
Tax Payment
Common Stock
2025-02-11$245.14/sh−134$32,849→ 6,396.143 total
Exercise/Conversion
Common Stock
2025-02-11+473→ 6,530.143 total
Award
Restricted Stock Unit
2025-02-11+2,420→ 5,061 total
→ Common Stock (2,420 underlying)

Footnotes (7)

[F1]Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
[F2]Stock withholding to satisfy tax withholding obligations.
[F3]Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.
[F4]The option vested in three equal annual installments beginning on the date reflected in this column.
[F5]The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026.
[F6]This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
[F7]The Restricted Stock Units vested in three equal annual installments beginning on February 11, 2023 and are now fully vested.

Documents

1 file